Results 101 to 110 of about 60,982 (185)

Gross tumor assessment is not a reliable measure of the efficacy of chemo-preventive agents for breast cancer in preclinical mouse models. [PDF]

Sci Rep
Bhardwaj A, Koh A, Embury MD, Sandhu J, Rojo RD, Albarracin CT, Bedrosian I.   +6 more
europepmc   +1 more source

Emerging Oncogenic and Immunoregulatory Roles of BST2 in Human Cancers. [PDF]

Biomedicines
Kim C, Choi S, Park JW.
europepmc   +1 more source

Propranolol enhances the oncolytic effect of newcastle disease virus on canine mammary tumor cell by modulating the IFN-I-mediated JAK-STAT signaling pathway. [PDF]

Vet Q
Zhu Y, Xu M, Li M.
europepmc   +1 more source

RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to Bexarotene. [PDF]

Biomedicines
Chowdhury AS, Reich LA, Liby KT, Yeh ES, Leal AS.   +4 more
europepmc   +1 more source

Intraductal Injection of Adenoviruses to Perform Lineage Tracing in the Mammary Gland. [PDF]

J Mammary Gland Biol Neoplasia
Chen X, Han S, Zhao D, Li Z.
europepmc   +1 more source

Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ. [PDF]

Breast Cancer Res
Hladik C, Elayapillai SP, Dogra S, Bruns M, Wellberg EA, Filatenkov A, Behbod F, Hannafon BN.   +7 more
europepmc   +1 more source

Prevalence of Mouse Mammary Tumor Virus-Like Virus in Breast Milk and Associated Factors of Exposure Among Healthy Nursing Women in Morocco. [PDF]

Cureus
Cherkani Hassani A, Slaoui M, Benfathallah B, Ghanname I, Razine R, Attaleb M, El Mzibri M, Mouane N.   +7 more
europepmc   +1 more source

Characterization of HER2-Positive Murine Breast Cancer Models for Investigating HER2-Targeted Therapy and Immunotherapy. [PDF]

Cancers (Basel)
Lu Y, Lee BP, Eli AV, Lynch SE, Faisal ARM, Moye J, Sorace AG.   +6 more
europepmc   +1 more source

Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. [PDF]

Cancer Immunol Res
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M.   +14 more
europepmc   +1 more source

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6. [PDF]

Proc Natl Acad Sci U S A
Fassl A, Palacios Espinoza M, Butter D, Kolodziejczyk A, Seehawer M, Hill C, Ning X, Branigan TB, Peñailillo J, Saengboonmee C, Jadhav H, Charbonnier LM, Waks AG, Strawser C, McDonnell DP, Shapiro GI, Tolaney SM, Polyak K, Sammons S, Wucherpfennig KW, Sicinski P.   +20 more
europepmc   +1 more source